Supplemental Table 6: Total number of mutations across 12 cancer predisposing genes among ovarian cancer cases and controls in the NHS, NHSII, and CPSII</p
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibi...
Supplemental Table 2: Mutation frequencies in ovarian cancer cases and controls and risk of ovarian ...
Supplemental Table 5: Mutation frequencies in ovarian cancer cases and controls in the NHS, NHSII, a...
Supplemental Table 3: Mutation frequencies in invasive ovarian cancer cases and controls and risk of...
Supplemental Table 4: Mutation frequencies in high grade serous, endometroid, or poorly differentiat...
Supplemental Table 1: Characteristics from cohort (2004 NHS; 2007 NHSII, and baseline in CPSII) comp...
Supplemental Figure 1: Kaplan-Meier survival curves for all-cause mortality among cases with Type II...
Supplemental Figure 2: Kaplan-Meier survival curves for ovarian cancer-specific mortality among case...
Item does not contain fulltextGermline mutations in BRCA1 and BRCA2 are associated with increased ri...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibi...
Supplemental Table 2: Mutation frequencies in ovarian cancer cases and controls and risk of ovarian ...
Supplemental Table 5: Mutation frequencies in ovarian cancer cases and controls in the NHS, NHSII, a...
Supplemental Table 3: Mutation frequencies in invasive ovarian cancer cases and controls and risk of...
Supplemental Table 4: Mutation frequencies in high grade serous, endometroid, or poorly differentiat...
Supplemental Table 1: Characteristics from cohort (2004 NHS; 2007 NHSII, and baseline in CPSII) comp...
Supplemental Figure 1: Kaplan-Meier survival curves for all-cause mortality among cases with Type II...
Supplemental Figure 2: Kaplan-Meier survival curves for ovarian cancer-specific mortality among case...
Item does not contain fulltextGermline mutations in BRCA1 and BRCA2 are associated with increased ri...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian canc...
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibi...